Hugel, Inc. (KOSDAQ:145020)
South Korea · Delayed Price · Currency is KRW 244,500
-1,000 (-0.41%)
Jun 12, 2026, 3:30 PM KST
Hugel Market Cap
Hugel has a market cap or net worth of 2.64 trillion as of June 12, 2026. Its market cap has decreased by -29.18% in one year.
Market Cap
2.64T
Enterprise Value
2.12T
Revenue
451.93B
Ranking
n/a
PE Ratio
17.79
Stock Price
244,500.00
Market Cap Chart
Since December 24, 2015, Hugel's market cap has increased from 552.70B to 2.64T, an increase of 377.82%. That is a compound annual growth rate of 16.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 2.64T | 6.07% |
| Dec 30, 2025 | 2.49T | -19.40% |
| Dec 30, 2024 | 3.09T | 84.38% |
| Dec 28, 2023 | 1.68T | 4.84% |
| Dec 29, 2022 | 1.60T | -14.29% |
| Dec 30, 2021 | 1.86T | -20.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.95T |
| HLB Co., Ltd. | 6.45T |
| Peptron | 5.64T |
| LigaChem Biosciences | 4.97T |
| D&D Pharmatech | 3.81T |
| Voronoi | 3.73T |
| SK bioscience | 3.09T |
| PharmaResearch | 2.92T |